Brief: Delta-Fly Pharma Inc. Phase I/Ii Study Of Dfp-10917 And Venetoclax In Aml Patients Begins With Promising Initial Data
28/10/2024 11:59
Oct 28 (Reuters) - Delta-Fly Pharma Inc 4598.T :
* DELTA-FLY PHARMA INC.: PHASE I/II STUDY OF DFP-10917 AND
VENETOCLAX IN AML PATIENTS BEGINS WITH PROMISING INITIAL DATA
Source text: ID:nBw8WhwJ9a
Further company coverage: 4598.T
((Reuters.Briefs@thomsonreuters.com))